25 years of experience in the treatment of chronic myeloid leukemia with tyrosine kinase inhibitors: results, opportunities, questions
Article in Meditsinskiy sovet = Medical Council (January 2024)
The most recent citing publications are shown below. View all 44 publications that cite this research output on Dimensions.
Contribution of intracranial vessel wall magnetic resonance imaging in nilotinib‐associated vascular adverse effects diagnosis
Article in eJHaem (August 2023)
Adverse effects of tyrosine kinase inhibitors in cancer therapy: pathophysiology, mechanisms and clinical management
Article in Signal Transduction and Targeted Therapy (July 2023)